Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review

Background Cancer cases in the Kingdom of Saudi Arabia (KSA) have tripled in recent years. Quality of Life (QoL) measurements are crucial for healthcare professionals because they reveal important information about how patients respond to drugs and their general health. This study aimed to collect a...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah U. Althemery, Rawan Alzahrani, Nura Alajlan, Abdullah M. Alrajhi
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/20523211.2024.2449036
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841543117000409088
author Abdullah U. Althemery
Rawan Alzahrani
Nura Alajlan
Abdullah M. Alrajhi
author_facet Abdullah U. Althemery
Rawan Alzahrani
Nura Alajlan
Abdullah M. Alrajhi
author_sort Abdullah U. Althemery
collection DOAJ
description Background Cancer cases in the Kingdom of Saudi Arabia (KSA) have tripled in recent years. Quality of Life (QoL) measurements are crucial for healthcare professionals because they reveal important information about how patients respond to drugs and their general health. This study aimed to collect and summarise articles exploring the QoL of patients undergoing oncology treatments in KSA.Methods This systematic review captured articles on the Quality of Life of patients undergoing oncology treatments living in the KSA from 2000–2023. A query was established by adapting (PICOS) guidelines for systematic research. A systematic review accelerator (SRA) was used to organise the search and enable multiple reviewers to conduct and validate the process.Results Twelve articles met the inclusion criteria. Riyadh and Jeddah contributed to all publications. A total of 2,430 patients with cancer were surveyed; 1,377 patients were female (56.67%) with an average age of 51.23 years. Six articles mentioned pharmacological interventions, whereas the remaining articles did not mention which pharmacology had been utilised.Conclusion This systematic review highlights the recent attention given to the patient’s reported outcomes of cancer patients. Further research on rare cancer types is required, particularly for generic instruments.
format Article
id doaj-art-aa94553a2e224d058c6a8784539dabff
institution Kabale University
issn 2052-3211
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Pharmaceutical Policy and Practice
spelling doaj-art-aa94553a2e224d058c6a8784539dabff2025-01-13T15:41:54ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112025-12-0118110.1080/20523211.2024.2449036Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic reviewAbdullah U. Althemery0Rawan Alzahrani1Nura Alajlan2Abdullah M. Alrajhi3Department of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi ArabiaDepartment of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi ArabiaDepartment of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi ArabiaClinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi ArabiaBackground Cancer cases in the Kingdom of Saudi Arabia (KSA) have tripled in recent years. Quality of Life (QoL) measurements are crucial for healthcare professionals because they reveal important information about how patients respond to drugs and their general health. This study aimed to collect and summarise articles exploring the QoL of patients undergoing oncology treatments in KSA.Methods This systematic review captured articles on the Quality of Life of patients undergoing oncology treatments living in the KSA from 2000–2023. A query was established by adapting (PICOS) guidelines for systematic research. A systematic review accelerator (SRA) was used to organise the search and enable multiple reviewers to conduct and validate the process.Results Twelve articles met the inclusion criteria. Riyadh and Jeddah contributed to all publications. A total of 2,430 patients with cancer were surveyed; 1,377 patients were female (56.67%) with an average age of 51.23 years. Six articles mentioned pharmacological interventions, whereas the remaining articles did not mention which pharmacology had been utilised.Conclusion This systematic review highlights the recent attention given to the patient’s reported outcomes of cancer patients. Further research on rare cancer types is required, particularly for generic instruments.https://www.tandfonline.com/doi/10.1080/20523211.2024.2449036Cancerquality of lifeSaudi Arabiabreast cancercolorectal cancer
spellingShingle Abdullah U. Althemery
Rawan Alzahrani
Nura Alajlan
Abdullah M. Alrajhi
Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review
Journal of Pharmaceutical Policy and Practice
Cancer
quality of life
Saudi Arabia
breast cancer
colorectal cancer
title Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review
title_full Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review
title_fullStr Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review
title_full_unstemmed Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review
title_short Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review
title_sort quality of life for patients on oncology treatments in the kingdom of saudi arabia a systematic review
topic Cancer
quality of life
Saudi Arabia
breast cancer
colorectal cancer
url https://www.tandfonline.com/doi/10.1080/20523211.2024.2449036
work_keys_str_mv AT abdullahualthemery qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview
AT rawanalzahrani qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview
AT nuraalajlan qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview
AT abdullahmalrajhi qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview